Review:
Teriparatide
overall review score: 4.2
⭐⭐⭐⭐⭐
score is between 0 and 5
Teriparatide is a recombinant form of parathyroid hormone (PTH) used as an anabolic agent in the treatment of osteoporosis. It stimulates new bone formation by promoting osteoblast activity, thereby increasing bone density and reducing fracture risk in patients with severe osteoporosis.
Key Features
- Biological activity mimicking natural parathyroid hormone
- Administered via daily subcutaneous injections
- Enhances bone formation and increases bone mineral density
- Typically prescribed for severe or high-risk osteoporosis cases
- Used for up to 24 months due to potential side effects
Pros
- Effectively increases bone density and reduces fracture risk
- Stimulates new bone formation through anabolic mechanism
- Useful for patients with severe osteoporosis or those unresponsive to other treatments
Cons
- Requires daily injections, which may affect patient compliance
- Potential side effects include nausea, limb pain, and hypercalcemia
- High cost compared to other osteoporosis medications
- Limited treatment duration due to the risk of osteosarcoma observed in animal studies